Sycale Advisors’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
DTC
PAI
Sycale Advisors's INSM Position: Q2 2023 in Review
Sycale Advisors sold out of Insmed (INSM) in Q2 2023, closing a stake of 80,236 shares — an estimated $1.37M sold.
Sycale Advisors first reported a position in INSM in Q4 2019 and held it in 14 quarters. The position peaked at $12.6M in Q1 2021. 223 funds tracked by Wall St. Rank hold INSM as of Q2 2023.
- Sycale Advisors reported no remaining Insmed position as of Q2 2023 after selling out during the quarter.
- Sycale Advisors sold 80,236 Insmed shares in Q2 2023, an estimated $1.37M.
- Sycale Advisors first reported a position in Insmed in Q4 2019 and held it in 14 quarters.
- Sycale Advisors's Insmed position peaked at $12.6M in Q1 2021.
- 223 funds tracked by Wall St. Rank held Insmed as of Q2 2023.
Based on Sycale Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.